Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-24

FDA Approved: LYNKUET — Original Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Lynkuet (elinzanetant) from Bayer HealthCare Pharmaceuticals Inc. under an original NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LYNKUET (elinzanetant)

Snippet

ORIG AP for LYNKUET (ELINZANETANT)